Purchase this article with an account.
Akihisa Matsubara, Toru Nakazawa, Kosuke Noda, Haicheng She, Edward Connolly, Tara A. Young, Yuichiro Ogura, Evangelos S. Gragoudas, Joan W. Miller; Photodynamic Therapy Induces Caspase-Dependent Apoptosis in Rat CNV Model. Invest. Ophthalmol. Vis. Sci. 2007;48(10):4741-4747. doi: https://doi.org/10.1167/iovs.06-1534.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
purpose. To investigate the mechanism of cell death in laser-induced choroidal neovascularization (CNV) after photodynamic therapy (PDT).
methods. PDT was performed in Brown-Norway rats using laser light at a wavelength of 689 nm, irradiance of 600 mW/cm2, and fluence of 25 J/cm2 after intravenous injection of verteporfin at the doses of 3, 6, and 12 mg/m2. Apoptotic cells in CNV were detected by TUNEL assay at 1, 3, 6, 15, 24, and 48 hours after PDT. Caspase activation at 1, 3, 6, 15, and 24 hours after PDT was determined by immunohistochemistry (IHC) with a cleaved caspase-3 or -9 antibody. Akt activity was determined by Western blot and IHC with a phosphorylated-Akt (pAkt) antibody. To investigate the roles of Akt in PDT-induced apoptosis, insulin-like growth factor (IGF)-1, an Akt activator, with or without wortmannin, an inhibitor of PI3K-Akt pathway, was injected into the vitreous before PDT.
results. The number of TUNEL-positive cells in CNV increased at 3 hours after PDT and peaked at 6 hours, showing a dose dependence of verteporfin. Caspase activation was detected in TUNEL-positive cells. Dephosphorylation of Akt in CNV occurred within 1 hour. IGF-1 significantly activated Akt and suppressed the number of TUNEL-positive cells in CNV, and the effects of IGF-1 were diminished by wortmannin.
conclusions. PDT induced caspase-dependent apoptosis in CNV. These results suggest that PDT leads to dephosphorylation of Akt and subsequent activation of the caspase-dependent pathway. Understanding the intracellular signaling mechanisms of apoptosis in PDT may lead to more selective and effective treatment of CNV secondary to age-related macular degeneration.
This PDF is available to Subscribers Only